Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
affordable care act
cancer
cancer immunotherapy
car-t immunotherapy
clinical trials
deals
eli lilly
fda
johnson & johnson
nonalcoholic steatohepatitis
What
bio
nash
3
×
roundup
companies
drug
news
american
approval
approved
based
best
biogen’s
biopharmaceutical
continue
convo
crash
debate
digital
disease
earlier
epidemic
failures
fatty
fda
frenzied
growing
healthcare
industry
kind
known
led
littered
liver
merck
new
people
pharmaceutical
policy
politicians
pressure
Language
Current search:
nash
×
" bristol-myers squibb "
×
biotech
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More